Spots Global Cancer Trial Database for following complete or partial response to platinum based chemotherapy
Every month we try and update this database with for following complete or partial response to platinum based chemotherapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy | NCT01874353 | Platinum Sensit... BRCA Mutated Relapsed Ovaria... Following Compl... | Olaparib 300mg ... Placebo to matc... | 18 Years - 130 Years | AstraZeneca | |
Olaparib Tablets Maintenance Monotherapy Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy | NCT03534453 | Relapsed Ovaria... Following Compl... Platinum Sensit... | Olaparib 300mg ... | 18 Years - 130 Years | AstraZeneca |